Symbol="TGTX"
AssetType="Common Stock"
Name="TG Therapeutics Inc"
Description="TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York."
CIK="1001316"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3728924000"
EBITDA="-162664000"
PERatio="None"
PEGRatio="0"
BookValue="0.198"
DividendPerShare="0"
DividendYield="0"
EPS="-1.28"
RevenuePerShareTTM="0.063"
ProfitMargin="0"
OperatingMarginTTM="-19.01"
ReturnOnAssetsTTM="-0.407"
ReturnOnEquityTTM="-1.704"
RevenueTTM="8572000"
GrossProfitTTM="2520000"
DilutedEPSTTM="-1.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.871"
AnalystTargetPrice="30.69"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="249.27"
PriceToBookRatio="10.88"
EVToRevenue="198.82"
EVToEBITDA="-4.349"
Beta="2.047"
num_52WeekHigh="35.67"
num_52WeekLow="4.86"
num_50DayMovingAverage="27.55"
num_200DayMovingAverage="15.74"
SharesOutstanding="149396000"
DividendDate="None"
ExDividendDate="None"
symbol="TGTX"
open="25.07"
high="25.93"
low="24.69"
price="24.96"
volume="5363749.00"
latest_trading_day="2023-07-07"
previous_close="23.04"
change="1.92"
change_percent="8.3333%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="3997716"
Change_recent_avg="0.06"
Delta_recent_avg="1.46"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="0.2"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_negative_thumbnail_id_2="169"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="977"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_positive_thumbnail_id_2="676"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
